Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
| Revenue | $4.43B | $4.92B | $5.81B | $6.04B | $6.26B | $6.12B | $5.96B |
| Revenue growth | — | 11.0% | 18.0% | 3.9% | 3.6% | -2.2% | -2.5% |
| Gross profit | $1.91B | $2.11B | $2.43B | $2.43B | $2.35B | $2.32B | $2.31B |
| Gross margin | 43.0% | 42.8% | 41.8% | 40.2% | 37.6% | 38.0% | 38.7% |
| Operating income | $111M | $194M | $266M | $226M | -$1.18B | $7.05M | $120M |
| Operating margin | 2.5% | 4.0% | 4.6% | 3.7% | -18.9% | 0.1% | 2.0% |
| Net income | -$95.9M | -$26.5M | $164M | $90.8M | -$1.28B | -$102M | $9.07M |
| Net margin | -2.2% | -0.5% | 2.8% | 1.5% | -20.5% | -1.7% | 0.2% |
| EPS (diluted) | -$0.46 | -$0.13 | $0.62 | $0.34 | -$4.78 | -$0.37 | $0.03 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $110M | $269M | $358M | $346M | $216M | $178M | $314M |
| Capital expenditures | $157M | $160M | $239M | $278M | $226M | $128M | $127M |
| Free cash flow | -$46.6M | $109M | $119M | $68.0M | -$9.88M | $49.7M | $187M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $155M | $111M | $212M | $202M | $125M | $166M | $257M |
| Total assets | — | $6.08B | $6.50B | $6.61B | $5.36B | $5.19B | $5.17B |
| Total liabilities | — | $4.02B | $4.24B | $4.23B | $4.18B | $4.08B | $4.01B |
| Long-term debt | — | $1.65B | $1.64B | $1.63B | $1.58B | $1.58B | $1.49B |
| Shareholders' equity | $561M | $2.07B | $2.27B | $2.38B | $1.18B | $1.11B | $1.16B |
| Retained earnings | — | -$22.3M | $142M | $233M | -$1.05B | -$1.15B | -$1.14B |
| Shares (wtd avg diluted) | 209K | 211K | 265K | 266M | 268M | 273M | 286M |
Every figure is extracted from Petco Health & Wellness Company, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.